header-logo
Medical College of Wisconsin School of Graduate Studies U1-Research 2F Microscope Lab-Grad-hero
Sara Adibfar

Sara Adibfar

Graduate Student

Program

  • Interdisciplinary Program in Biomedical Sciences

Contact Information

Biography

Mentor: Rotating
Year Entered MCW: 2025
Previous Education: BS, Cellular and Molecular Biology, 2017; MS, Biotechnology; Medical Immunology, 2022

Research Interests

My research interests focus on cancer therapy and immune-related disorders, with an emphasis on translational and clinically relevant research. I am motivated by work that has the potential to directly impact patient care.

Publications

Khodakarami A, Adibfar S, Karpisheh V, Abolhasani S, Jalali P, Mohammadi H, Gholizadeh Navashenaq J, Hojjat-Farsangi M, Jadidi-Niaragh F, “The molecular biology and therapeutic potential of Nrf2 in leukemia”, Cancer Cell International, 2022, Vol 22. [Click] (IF= 6.4, Q2)

Hosseinpour Feizi, A. A., Vakili-Samiani, S., Adibfar, S., Hojjat-Farsangi, M., Atyabi, F., Movassaghpour, A. A., and Jadidi-Niaragh, F, “Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles”, Elsevier Journal of Drug Delivery Science and Technology, 2022, Vol 77. [Click] (IF= 5.0, Q1)

Adibfar S, Masjedi A, Nazer A, Rashidi B, Karpisheh V, Izadi S, Hassannia H, Navashenaq JG, Mohammadi H, Hojjat-Farsangi M, Tarokhian H, “Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses”, Life Sciences, 2022, Vol 309. [Click] (IF=6.7, Q1)

Adibfar S, Elveny M, Kashikova HS, Mikhailova MV, Farhangnia P, Vakili-Samiani S, Tarokhian H, Jadidi-Niaragh F, “The molecular mechanisms and therapeutic potential of EZH2 in breast cancer”, Life Sciences, 2021, Vol 286. [Click] (IF=6.7, Q1)

Vakili-Samiani S, Jalil AT, Abdelbasset WK, Yumashev AV, Karpisheh V, Jalali P, Adibfar S, Ahmadi M, Feizi AA, Jadidi-Niaragh F, “Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies”, DNA Repair, 2021, Vol 107. [Click] (IF= 4.35, Q1)

(Oral Presentation) Sara Adibfar, Hanieh Tarokhian, Farhad Jadidi Niaragh. “Coinhibition of CD73 and EZH2 molecules suppresses the growth and development of 4T1 breast cancer cells, in vitro”, 15th international congress of immunology and allergy, 2020, Ahvaz, Iran


© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.